TY - JOUR T1 - The prevalence of inverse health consequences of COVID-19 vaccines: A post-vaccination study JO - Vacunas T2 - AU - Shrestha,Yogendra AU - Venkataraman,Rajesh SN - 15769887 M3 - 10.1016/j.vacun.2022.03.002 DO - 10.1016/j.vacun.2022.03.002 UR - https://www.elsevier.es/es-revista-vacunas-72-articulo-the-prevalence-inverse-health-consequences-S1576988722000310 AB - BackgroundCOVID-19 vaccinations are intended to help produce neutralizing antibodies which target surface spike protein to combat the SARS-Cov-2 virus. Similarly, COVID-19 recovered patients exhibit high levels of SARS-CoV-2 neutralizing antibodies, which predominantly target the surface spike protein and are associated with the occurrence of health consequences in survivors. ObjectiveThe aim of the study is to explore the long-term health consequences of the COVID-19 vaccines. MethodologyA prospective, exploratory observational study conducted both online and offline using various questionnaires with all immunized individuals who had been inoculated for at least a month following their last COVID-19 vaccine either AZD1222® or BBV152® vaccines. ResultsWe evaluated 258 individuals who had taken the COVID vaccine and found that females made up the majority (54.3%) and that the mean age was 24 years. Post-vaccination long-term health issues were reported by 36.05% (93) of the participants, with 37.86% (53) of females and 33.9% (40) of males (p = 0.292). Myalgia was reported by 20.15% (52), fatigue was 13.95% (36), paresthesia was 1.16% (3), ageusia was 0.77% (2), sadness/irritability was 2.31% (6), and lack of concentration/excessive worry was 3.1% (8). ConclusionsMyalgia, fatigue, paresthesia, ageusia, coughs and colds, dyspnea, sadness/irritability, and lack of concentration/excessive worry are health consequences related to the COVID-19 vaccination which follow a similar pattern of post-COVID syndrome. ER -